Navigation Links
Cardiome Discloses Chairman And CEO's Involuntary Share Sale
Date:11/28/2008

NASDAQ: CRME TSX: COM

VANCOUVER, Nov. 28 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today disclosed that its Chairman and Chief Executive Officer, Bob Rieder, was recently subject to involuntary margin sales of 45,000 common shares from his direct holding of Cardiome stock.

Mr. Rieder commented, "I am very disappointed to have been required to involuntarily sell any shares of Cardiome, particularly at such an inopportune time; however the global financial crisis and associated market decline has had a profound impact on all stocks including our own. Since joining Cardiome as CEO in 1998, I have always practiced my belief that the leader of a company should have a direct and material financial stake in the company's success, and I have consistently held a substantial proportion of my personal assets in Cardiome shares. My faith and confidence in Cardiome's success is absolutely undiminished as we drive the company forward to the exciting times that lie ahead."

About Cardiome Pharma Corp.

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on the NASDAQ National Market (CRME) and the Toronto Stock Exchange (COM). For more information, please visit our web site at www.cardiome.com.

Forward-Looking Statement Disclaimer

Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including without limitation statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "i
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardiome Provides Regulatory Update
2. Cardiome To Release Second Quarter Results And Hold Conference Call
3. Cardiome Announces Preferred Share Financing
4. Cardiome Announces Positive Phase 2b Results For Oral Vernakalant
5. Cardiome To Hold Conference Call
6. Cardiome Reports First Quarter Results
7. Cardiome To Release 2008 First Quarter Results
8. Cardiome To Release 2007 Results
9. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
10. Cardiome And Astellas Announce Regulatory Update
11. Cardiome to Hold Investor Update Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Williams Rejuva Center is ... their Latham aesthetic office. Dr. Edwin Williams, known ... the first surgeons in the area to employ the ... technique is faster and safer than similar products available ... a noninvasive procedure , designed to dramatically improve ...
(Date:8/29/2014)... Thompson HealthDay Reporter , THURSDAY, ... the early days of the Ebola outbreak in West Africa ... and spreads. Researchers report in the Aug. 28 online ... the following: The Ebola strains responsible for the ... the very first recorded outbreak of Ebola in central Africa ...
(Date:8/29/2014)... 2014 (HealthDay News) -- Researchers have discovered that people ... Dyslexia -- the most commonly diagnosed learning disorder ... and writing. Previous research showed that brain activity ... those studies focused only on a small number of ... to analyze how multiple brain regions use networks to ...
(Date:8/29/2014)... VHA Central Atlantic recognized Novant Health ... honoring nine facilities for meeting or exceeding national performance ... Health, providing quality, affordable healthcare for our communities has ... executive vice president and chief medical officer. “These awards ... for each and every one of our patients.” , ...
(Date:8/29/2014)... Port Washington, New York (PRWEB) August 29, 2014 ... that has long been dedicated to protecting the rights ... that the Drug Enforcement Administration (DEA) has announced new ... Regulatory Affairs Professionals Society (RAPS) report dated ... combination products as Schedule II drugs under federal law. ...
Breaking Medicine News(10 mins):Health News:Williams Revjuva Center Brings Micro-Needling to Latham 2Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Novant Health Recognized for Excellence in Clinical Care 2Health News:Novant Health Recognized for Excellence in Clinical Care 3Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 2Health News:The Drug Enforcement Agency (DEA) Just Announced Plans to Regulate All Hydrocodone Combination Drugs as Schedule II Drugs, Parker Waichman LLP Comments 3
... scientific study has backed them up by showing that dating, ... they really are. Researchers at the University of Alberta in ... Victoria, carried out the study. ,As a part ... 700 adolescents between 12 to 19 years of age from ...
... the killing last year of an unarmed man on his ... mandatory breathalyzer tests after such shootings. Sean Bell, a 23-year-old ... girlfriend, died in a hail of 50 bullets hours before ... fire on Bells car outside a topless bar. Two ...
... Kerala Tuesday remained glued to their seats in the assembly ... raging fever that has killed 76 people. ... the day. Our only demand is that the government should ... former chief minister Oommen Chandy, now leader of the United ...
... (IIT), Kharagpur, in West Bengal is the top technology ... which held the position last year, a survey ... Data Quest, a technology magazine in India, and International ... IITs have bagged the top seven positions. IIT-Kharagpur climbed ...
... Research from The University of Arizona Sarver Heart Center ... heart disease. Excessive body weight is associated ... left ventricle, the hearts pumping chamber. Known to physicians ... lead to heart failure and rhythm problems. ...
... from Princess Margaret Hospital (PMH) are using a new ... therapy , takes less than an hour and eliminates ... PMH team combined the expertise of surgeons, radiation medicine ... perform its first procedure. It marked the first time ...
Cached Medicine News:Health News:Dating, Drugs and Sex Make Teens Feel Older Than They are 2Health News:Breathalyzer Tests for Cops Involved in Shootings 2Health News:Kerala Opposition's Unique Protest Over Fever Deaths 2Health News:IIT-Kharagpur the Leading Technology College in India: Survey 2Health News:Interoperative Radiotherapy for Breast Cancer Patients 2
(Date:8/28/2014)... Reportlinker.com announces that a new market ... North America Aesthetic Lasers and Energy Devices ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North America Aesthetic Lasers ... Summary GlobalData,s new report, "North America Aesthetic ... provides key market data on the North America ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... new market research report is available ... Laboratories, Safety and Compliance Services Industry ... and Revenue Forecasts to 2021, NAIC ... .html Testing Laboratories, ...
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 /PRNewswire/ ... report is available in its catalogue: ... to 2020 http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Market Outlook to 2020 Summary GlobalData,s ... Market Outlook to 2020", provides key market data ...
Breaking Medicine Technology:North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9
... March 30 A new study, published in the ... of as little as 8 grams (1/3 ounce) of ... body fat percentage, serum total cholesterol, and fasting blood ... grams of "Sun Chlorella A" tablets each morning and ...
... phase III trial -SOUTH SAN FRANCISCO, Calif., March 30 ... their phase II study of HPN-100 for the treatment ... on March 27th at the 16th Annual Clinical Genetics ... Brendan Lee, M.D., Ph.D., Howard Hughes Medical Institute Investigator ...
Cached Medicine Technology:First Human Study to Show 'Sun Chlorella A' Supports Heart Health 2Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 2Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 3Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 4
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
Medicine Products: